| Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP … S Branford, Z Rudzki, S Walsh, I Parkinson, A Grigg, J Szer, K Taylor, ... Blood 102 (1), 276-283, 2003 | 990 | 2003 |
| Hematopoietic stem cell transplantation: a global perspective A Gratwohl, H Baldomero, M Aljurf, MC Pasquini, LF Bouzas, A Yoshimi, ... Jama 303 (16), 1617-1624, 2010 | 822 | 2010 |
| Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation NS Majhail, JD Rizzo, SJ Lee, M Aljurf, Y Atsuta, C Bonfim, LJ Burns, ... Revista brasileira de hematologia e hemoterapia 34, 109-133, 2012 | 751 | 2012 |
| Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease R Zeiser, N von Bubnoff, J Butler, M Mohty, D Niederwieser, R Or, J Szer, ... New England Journal of Medicine 382 (19), 1800-1810, 2020 | 556 | 2020 |
| One million haemopoietic stem-cell transplants: a retrospective observational study A Gratwohl, MC Pasquini, M Aljurf, Y Atsuta, H Baldomero, L Foeken, ... The Lancet Haematology 2 (3), e91-e100, 2015 | 455 | 2015 |
| A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia G Heil, D Hoelzer, MA Sanz, K Lechner, JA Liu Yin, G Papa, L Noens, ... Blood, The Journal of the American Society of Hematology 90 (12), 4710-4718, 1997 | 399 | 1997 |
| Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global … D Niederwieser, H Baldomero, J Szer, M Gratwohl, M Aljurf, Y Atsuta, ... Bone marrow transplantation 51 (6), 778-785, 2016 | 385 | 2016 |
| All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4) HJ Iland, K Bradstock, SG Supple, A Catalano, M Collins, M Hertzberg, ... Blood, The Journal of the American Society of Hematology 120 (8), 1570-1580, 2012 | 342 | 2012 |
| Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study AG Kulasekararaj, A Hill, ST Rottinghaus, S Langemeijer, R Wells, ... Blood, The Journal of the American Society of Hematology 133 (6), 540-549, 2019 | 312 | 2019 |
| Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia N Schmitz, M Beksac, D Hasenclever, A Bacigalupo, T Ruutu, A Nagler, ... Blood, The Journal of the American Society of Hematology 100 (3), 761-767, 2002 | 303 | 2002 |
| Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase … M Brune, S Castaigne, J Catalano, K Gehlsen, AD Ho, WK Hofmann, ... Blood 108 (1), 88-96, 2006 | 297 | 2006 |
| Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia BJP Huntly, AG Reid, AJ Bench, LJ Campbell, N Telford, P Shepherd, ... Blood, The Journal of the American Society of Hematology 98 (6), 1732-1738, 2001 | 296 | 2001 |
| Prospective, randomized, double-blind, phase III clinical trial of anti–T-lymphocyte globulin to assess impact on chronic graft-versus-host disease–free survival in patients … RJ Soiffer, HT Kim, J McGuirk, ME Horwitz, L Johnston, MM Patnaik, ... Journal of Clinical Oncology 35 (36), 4003, 2017 | 281 | 2017 |
| Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation CG Mullighan, S Heatley, K Doherty, F Szabo, A Grigg, TP Hughes, ... Blood, The Journal of the American Society of Hematology 99 (10), 3524-3529, 2002 | 257 | 2002 |
| Pegcetacoplan versus eculizumab in paroxysmal nocturnal hemoglobinuria P Hillmen, J Szer, I Weitz, A Röth, B Höchsmann, J Panse, K Usuki, ... New England Journal of Medicine 384 (11), 1028-1037, 2021 | 242 | 2021 |
| Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 241 | 2017 |
| Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria RJ Kelly, B Höchsmann, J Szer, A Kulasekararaj, S De Guibert, A Röth, ... New England Journal of Medicine 373 (11), 1032-1039, 2015 | 236 | 2015 |
| Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2 EA Copelan, JC Biggs, JM Thompson, P Crilley, J Szer, JP Klein, ... | 225 | 1991 |
| The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome–negative acute … DI Marks, T Wang, WS Pérez, JH Antin, E Copelan, RP Gale, B George, ... Blood, The Journal of the American Society of Hematology 116 (3), 366-374, 2010 | 212 | 2010 |
| A pilot randomized trial comparing CD34‐selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis J Moore, P Brooks, S Milliken, J Biggs, D Ma, M Handel, P Cannell, R Will, ... Arthritis & Rheumatism 46 (9), 2301-2309, 2002 | 208 | 2002 |
